Skip to main content
Log in

Clinical Trial of Sparfloxacin in the Treatment of Leprosy

  • Poster Presentations
  • Quinolone Activity against Intracellular Pathogens Including Mycobacteria
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • Franzblau SG, Biswas AN, Jenner P, Colston MJ. Double-blind evaluation of BACTEC and Buddemeyer-type radiorespirometric assays for in vitro screening of antileprosy agents. Leprosy Review 63: 125–133, 1992

    PubMed  CAS  Google Scholar 

  • Franzblau SG, White KE. Comparative in vitro activity of 20 fluoroquinolones against Mycobacterium leprae. Antimicrobial Agents and Chemotherapy 34: 229–231, 1990

    Article  PubMed  CAS  Google Scholar 

  • Grosset JH, Guelpa-Lauras CC, Perani EG, N’Deli LN. Clinical trial of pefloxacin and ofloxacin in the treatment of lepromatous leprosy. International Journal of Leprosy 58: 281–295, 1990

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Franzblau, S.G., Chan, G.P. Clinical Trial of Sparfloxacin in the Treatment of Leprosy. Drugs 45 (Suppl 3), 225–226 (1993). https://doi.org/10.2165/00003495-199300453-00066

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199300453-00066

Keywords

Navigation